In vitro cytotoxicity of novel pro-apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL
- 1 January 2009
- journal article
- Published by Taylor & Francis in Drug Delivery
- Vol. 16 (1) , 45-51
Abstract
The purpose of this study was to develope and characterize a micellar formulations of N-{[(2-hydroxy-5- nitrophenyl)amino]carbonothioyl}-3,5-dimethylbenzamide (DM-PIT-1)-a new small molecule non-lipid antagonist of phopshotidylinositol-3.4.5-triphopshate and inhibitor of the PI3-kinase pathway. Micelle-forming PEG(2000)-PE was used to solubilize DM-PIT-1. To improve the specificity of the micellar DM-PIT-1, cancer-targeting anti-nucleosomal mAb2C5 antibodies as well as Tumor necrosis factor- Related Apoptosis-Inducing Ligand (TRAIL) were attached to the surface of polymeric micelles. DM-PIT-1 was effectively incorporated (> 70%) into 14-16 nm micelles, which had a negative surface zeta potential of 4-5 mV. Micellar DM-PIT-1 demonstrated high in vitro cytotoxicity against various cancer cells. An improved potency of the dual-activity DM-PIT-1/TRAIL combination nanoparticles in inducing death of TRAIL-resistant cancer cells was shown. Efficacy of the TRAIL therapy was enhanced by combining it with the 2C5 antibody cancer-targeted micellar form of DM-PIT-1. In conclusion, DM-PIT-1 micellar preparations can be used for targeted combination therapy against TRAIL-resistant cancers.Keywords
This publication has 29 references indexed in Scilit:
- Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cellsInternational Journal of Pharmaceutics, 2008
- Design and Development of Water-Soluble Curcumin Conjugates as Potential Anticancer AgentsJournal of Medicinal Chemistry, 2007
- Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolventsEuropean Journal of Pharmaceutical Sciences, 2006
- Mechanistic Study of Solubility Enhancement of Nifedipine Using Vitamin E TPGS or Solutol HS-15Drug Delivery, 2006
- An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in miceHepatology, 2004
- p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groupsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2001
- Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micellesCancer Chemotherapy and Pharmacology, 2001
- Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy ReceptorsScience, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Histamine-releasing properties of Polysorbate 80in vitro andin vivo: correlation with its hypotensive action in the dogInflammation Research, 1985